CD

Tech, startup & travel enthusiast.

[CD @CDNYC4]

A great profile highlighting the BioVenture eLab and the thriving entrepreneurial ecosystem at
@WeillCornell and @Cornell https://t.co/MrzEkDGLlO

[CD @CDNYC4]

@donaldjdean how can I DM you?

[WCMBioVenture @WCMBioVenture]

Thank you to @VorBioPharma CEO, Robert Ang, for the inspiring discussion on entrepreneurship, leadership and perseverance to kick-off our Accelerating BioVenture Innovation entrepreneurship program! @CDNYC4 @jahanara98

[CD @CDNYC4]

Register for the @WeillCornell Accelerating BioVenture Innovation Kickoff! ABI is a 12-week entrepreneurship training program that builds teams and business plans around patented technologies - more information on the program and alumni here: https://t.co/PDL2LBh3Rc

[CD @CDNYC4]

@jack Great talk and vision!

[CD @CDNYC4]

Today! Interview with Volastra Therapeutics CEO, Charles Hugh-Jones. Volastra has raised $44 million seed financing to advance drug discovery programs to prevent cancer metastasis (WCM/MSKCC Spinout) https://t.co/LUTPqeG5XD https://t.co/oPy62ydxzm

[WCMBioVenture @WCMBioVenture]

Join us tomorrow evening for the @WeillCornell Final Pitch Night - the culmination of our Spring accelerator. Full list of teams and inventors available on the event page! https://t.co/8Wxvu5G8RZ @jahanara98 @CDNYC4

[CD @CDNYC4]

@wolfejosh Amazing... congratulations to all involved! Excited to watch this...

[CD @CDNYC4]

Amazing news @C2iGenomics! It has been incredible to watch Asaf & team over the years. They are doing groundbreaking work in cancer treatment - watch this one! https://t.co/d2vZqCE92F?

[CD @CDNYC4]

@Lux_Capital @wolfejosh @Forbes Wow 👏

[WCMBioVenture @WCMBioVenture]

Proud of @WeillCornell startup SmartHer led by Dr. Tamatha Fenster, @bmosadegh and @WCMBioVenture EIR @YaronDavidNYC on winning 1st place at the @umassm2d2 #200KChallenge! It has been a pleasure working with Dr. Fenster on her entrepreneurial journey #innovation #medtech

[CD @CDNYC4]

Such an amazing group of faculty and student innovators for our 2021 @WeillCornell Spring Business Plan Challenge! We look forward to working with our industry and investor mentors over the next 8-weeks!

[Olivier Elemento @ElementoLab]

Delighted to announce that Volastra has closed its expanded $44M Series A round and is starting a new partnership with Microsoft to develop image-based biomarkers in metastatic cancers ! https://t.co/3XD4y0nxmX

[CD @CDNYC4]

@karanbains @ucsfdem @abrahams_sara @UCSF @DrSharma_NY @TheGargFather @RTanouyeMDMBA @kshah74 @JHabboushe @lbralow @heatheryeomd @BrennaFarmerMD Congratulations @karanbains !

[John P. Leonard, MD @JohnPLeonardMD]

@"Fostering and Catalyzing Biotech Startups Out of Academia: Insights From the 2021 Weill Cornell Medicine Startup Symposium"https://t.co/WMpB1ULhiP on @LinkedIn

[Amplifyher Ventures @AmplifyherVC]

Congratulations to IntelliHealth, Fesarius Therapeutics, BioSleep Technologies and the exceptional women innovators at @WeillCornell @WCMBioVenture !

[Evan Noch @EvanNoch]

Very excited to present @BrainDestroke at the @WCMBioVenture eLab’s Startup Symposium today @WeillCornell @CDNYC4

[WCMBioVenture @WCMBioVenture]

The 2021 @WeillCornell Startup Symposium & InvestConnect Conference will take place on February 25. We have a great line-up of speakers and startups presenting, including keynote speaker Dr. Robert Langer! https://t.co/AGcpAWAK17

[CD @CDNYC4]

@wolfejosh @readwiseio save

[CD @CDNYC4]

Congratulations to @WeillCornell Professor & Chairman of Genetic Medicine, Dr. Ronald Crystal, and Lexeo Therapeutics CEO, Nolan Townsend, on the $85 million Series A financing to develop gene therapies for rare and non-rare monogenic diseases!

[Endpoints News @endpts]

Gene therapy long hauler Ronald Crystal is launching his own company, Lexeo Therapeutics, with an $85 million Series A to drive three of the company’s AAV-administered candidates to market.

https://t.co/kAnCHyvmYb

[CD @CDNYC4]

@Shripriya Very interesting @Shripriya. I recently read this article on a similar topic - both very thought provoking https://t.co/HrasVXyvxP